Core Viewpoint - The company, 百本医护 (02293.HK), reported a decrease in revenue and profit for the fiscal year ending June 30, 2025, indicating challenges in its financial performance and a need for strategic adjustments [1] Financial Performance - Revenue for the year is approximately HKD 74.4 million, representing a year-on-year decrease of about 21.5% [1] - Profit attributable to equity holders is approximately HKD 17.5 million, reflecting a year-on-year decline of about 43.3% [1] - The proposed final dividend is HKD 0.015 per ordinary share, down from HKD 0.025 per ordinary share in 2024 [1] Strategic Initiatives - The company is actively seeking new business opportunities and forming alliances with strategic partners to pursue various business ventures [1] - This strategy aims to enhance the diversification of the company's operations beyond its current geographical regions and core business [1] - The approach supports the company's goals for sustainable growth and maximizing shareholder returns [1]
百本医护(02293.HK)年度权益持有人应占溢利1750万港元 同比减少约43.3%